Emory University School of Medicine, Department of Pharmacology, Woodruff Memorial Research Building, Suite 6000, 101 Woodruff Circle, Atlanta, GA 30322, USA.
Expert Opin Ther Targets. 2011 Dec;15(12):1387-403. doi: 10.1517/14728222.2011.641533. Epub 2011 Dec 3.
Dystonia is a neurological disorder associated with twisting motions and abnormal postures, which compromise normal movements and can be both painful and debilitating. It can affect a single body part (focal), several contiguous regions (segmental), or the entire body (generalized), and can arise as a result of numerous causes, both genetic and acquired. Despite the diversity of causes and manifestations, shared clinical features suggest that common mechanisms of pathogenesis may underlie many dystonias.
Shared themes in etiologically-diverse dystonias exist at several biological levels. At the cellular level, abnormalities in the dopaminergic system, mitochondrial function and calcium regulation are often present. At the anatomical level, the basal ganglia and the cerebellum are frequently implicated. Global CNS dysfunction, specifically aberrant neuronal plasticity, inhibition and sensorimotor integration, are also observed in a number of dystonias. Using clinical data and data from animal models, this article seeks to highlight shared pathways that may be critical in understanding mechanisms and identifying novel therapeutic strategies in dystonia.
Identifying shared features of pathogenesis can provide insight into the biological processes that underlie etiologically diverse dystonias, and can suggest novel targets for therapeutic intervention that may be effective in a broad group of affected individuals.
肌张力障碍是一种与扭曲运动和异常姿势相关的神经系统疾病,会影响正常运动,导致疼痛和身体残疾。它可以影响身体的单个部位(局灶性)、多个连续区域(节段性)或整个身体(全身性),并且可能由多种遗传和获得性原因引起。尽管病因和表现形式多种多样,但共同的临床特征表明,许多肌张力障碍可能存在共同的发病机制。
在多种病因的肌张力障碍中存在着共同的主题,存在于几个生物学水平上。在细胞水平上,多巴胺能系统、线粒体功能和钙调节的异常常常存在。在解剖学水平上,基底神经节和小脑经常受到牵连。在许多肌张力障碍中也观察到中枢神经系统的整体功能障碍,特别是异常的神经元可塑性、抑制和感觉运动整合。本文利用临床数据和动物模型数据,旨在强调共同的途径,这可能对理解发病机制和确定新的治疗策略具有重要意义。
确定发病机制的共同特征可以深入了解导致不同病因的肌张力障碍的生物学过程,并提示可能对广泛受影响的个体有效的新型治疗干预靶点。